Earnings Call · Q3 FY2021·2021-11-15

Q3 21EPS -28.65%·Rev n/aQ2 21EPS +4.78%·Rev n/aQ1 21EPS +2.79%·Rev n/aQ4 20EPS +100.00%*·Rev n/a⚠ consensus missing

Arcadia Biosciences, Inc. RKDA

Matt Plavan — President and CEO

Pam Haley — Chief Financial Officer

−6.8%1d on move date−7.2% vs SPY3d−18.9%5d−28.6%

Research tier

Behavioral profile computed for 2 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more RKDA calls or request research access.

More RKDA calls Browse calls Request research access